Table I.
HPSE expression | |||||
---|---|---|---|---|---|
Variables | Total | Low (n=53) | High (n=75) | χ2 | P-value |
Sex | 0.760 | ||||
Male | 85 | 36 | 49 | 0.093 | |
Female | 43 | 17 | 26 | ||
Age (years) | 0.391 | ||||
≤60 | 54 | 20 | 34 | 0.735 | |
>60 | 74 | 33 | 41 | ||
Size (cm) | 0.373 | ||||
≤4 | 104 | 45 | 59 | 0.793 | |
>4 | 24 | 8 | 16 | ||
Tumor location | 0.493 | ||||
Head and neck | 85 | 37 | 48 | 0.470 | |
Body and tail | 43 | 16 | 27 | ||
Vascular invasion | 0.025 | ||||
Negative | 61 | 19 | 42 | 5.055 | |
Positive | 67 | 34 | 33 | ||
Differentiation | 0.012 | ||||
High/moderate | 58 | 31 | 27 | 6.339 | |
Poor and undifferentiated | 70 | 22 | 48 | ||
TNM stage | 0.023 | ||||
I–II | 62 | 32 | 30 | 5.163 | |
III–IV | 66 | 21 | 45 |
HPSE, heparanase.